Truist Securities Maintains Hold on Agilon Health, Raises Price Target to $112

Benzinga Newsdesk www.benzinga.com Positive 67.5%

Neg 0% Neu 0% Pos 67.5%

Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and raises the price target from $67 to $112.